1 results match your criteria: "Magdalena Special Hospital for Cardiovascular Surgery and Cardiology[Affiliation]"
Surgery and discontinuation of angiotensin converting enzyme inhibitors: current perspectives.
Curr Opin Anaesthesiol
February 2018
Department for Anesthesiology and Intensive Care, Magdalena Special Hospital for Cardiovascular Surgery and Cardiology, Krapinske Toplice.
Purpose Of Review: The current article reviews the current evidence for continuing or discontinuing angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) during the perioperative period.
Recent Findings: In patients undergoing treatment of hypertension with ACEIs or ARBs, there are both benefits associated with continuing these medications during the perioperative period and higher risk for perioperative hypotension and its complications.
Summary: Since the introduction of ACEIs and ARBs into clinical practice, their use during the perioperative period has been controversial.